The study and its comparison
Twenty-one adults completed two six-day laboratory sessions in a blinded crossover study. Sustained-release melatonin or placebo was taken before two daytime sleep periods following simulated night work. [1]
Melatonin prevented a reduction in sleep duration on the first treatment day, particularly in participants who struggled to sleep during daylight. It did not improve measured night-shift alertness, performance or mood. [1]
What the finding establishes
The short simulation cannot establish long-term workplace safety or a durable response. Circadian misalignment may remain even when a person sleeps longer. Funding and conflicts were not established from the abstract. The result is not permission to rely on a supplement before driving or other safety-critical work. [1]
A hypothetical distinction
Imagine daytime sleep lasts longer but overnight task performance stays unchanged. Sleep duration alone does not prove restored alertness.
| Detail | Interpretation |
|---|---|
| Measured outcome | Keep the endpoint specific |
| Study preparation | Not every retail product |
| Remaining uncertainty | Not resolved by a mechanism |
Sources for this article
- Effects of melatonin administration on daytime sleep after simulated night shift work.
Source consulted: 2026-09-19. This is a reference resource, not a claim that we conducted the studies or tested a product.